We are live on ! Find out more
ARAV

Aravive, Inc. Common Stock
ARAV

Delisted

ARAV was delisted on the 26th of January, 2024.

Back to rankings

30 hedge funds and large institutions have $19.2M invested in Aravive, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

33% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 6

0% more funds holding

Funds holding: 30 → 30 (0)

12% less capital invested

Capital invested by funds: $21.9M → $19.2M (-$2.68M)

Holders
30
Holders Change
–
Holders Change %
0%
% of All Funds
0.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
8
Reduced
6
Closed
2
Calls
$128K
Puts
–
Net Calls
+$128K
Net Calls Change
-$21K

Top Buyers

1
BBA
Baker Bros. Advisors
New York
+$337K
2
AG
Artal Group
Luxembourg
+$319K
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$141K
4
Renaissance Technologies
Renaissance Technologies
New York
+$112K
5
UBS Group
UBS Group
Switzerland
+$73.7K

Top Sellers

1
SIM
Spark Investment Management
New York
-$92K
2
California Public Employees Retirement System
California Public Employees Retirement System
California
-$83K
3
Parallax Volatility Advisers
Parallax Volatility Advisers
California
-$36.5K
4
Two Sigma Advisers
Two Sigma Advisers
New York
-$29.3K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$24.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
NLVP
1
New Leaf Venture Partners
New York
$5.82M – – –
BBA
2
Baker Bros. Advisors
New York
$2.91M +$337K +54,062 +13%
SB
3
Samsara BioCapital
California
$2.66M – – –
AG
4
Artal Group
Luxembourg
$1.84M +$319K +51,197 +20%
BlackRock
5
BlackRock
New York
$1.04M +$59.5K +9,544 +6%
Dimensional Fund Advisors
6
Dimensional Fund Advisors
Texas
$995K +$141K +22,603 +16%
Vanguard Group
7
Vanguard Group
Pennsylvania
$955K +$44.9K +7,200 +5%
Renaissance Technologies
8
Renaissance Technologies
New York
$890K +$112K +18,017 +14%
BOTOTLSJU
9
Board of Trustees of The Leland Stanford Junior University
California
$882K – – –
UBS Group
10
UBS Group
Switzerland
$406K +$73.7K +11,814 +21%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$181K +$449 +72 +0.2%
BCM
12
Bridgeway Capital Management
Texas
$132K – – –
Two Sigma Advisers
13
Two Sigma Advisers
New York
$103K -$29.3K -4,700 -22%
Northern Trust
14
Northern Trust
Illinois
$95K – – –
Bank of New York Mellon
15
Bank of New York Mellon
New York
$81K – – –
Morgan Stanley
16
Morgan Stanley
New York
$64K -$11.1K -1,784 -14%
PAM
17
Panagora Asset Management
Massachusetts
$43K -$636 -102 -1%
Acadian Asset Management
18
Acadian Asset Management
Massachusetts
$33K -$24.2K -3,877 -41%
Parallax Volatility Advisers
19
Parallax Volatility Advisers
California
$29K -$36.5K -5,858 -55%
MAM
20
Meeder Asset Management
Ohio
$6K – – –
Wells Fargo
21
Wells Fargo
California
$2K – – –
PA
22
Parallel Advisors
California
$1K – – –
JP Morgan Chase
23
JP Morgan Chase
New York
$1K +$854 +137 New
BNP Paribas Financial Markets
24
BNP Paribas Financial Markets
France
$846 +$879 +141 New
GT
25
Glenmede Trust
Pennsylvania
$8 – – –
1
2

ARAV Hedge Fund Activity: Q2 2019 in Review

30 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Aravive, Inc. Common Stock (ARAV) for Q2 2019, worth a combined $19.2M — down 12% from $21.9M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new ARAV positions and 2 closed out — a net gain of 1 holder — while 8 added to existing stakes and 6 trimmed.

The largest buyer was Baker Bros. Advisors, adding an estimated $337K. The largest seller was Spark Investment Management, exiting entirely with an estimated $92K sold.

  • 30 institutional investors held Aravive, Inc. Common Stock (ARAV) as of Q2 2019, unchanged from Q1 2019.
  • Funds reported $19.2M of Aravive, Inc. Common Stock stock for Q2 2019, down 12% quarter-over-quarter.
  • 3 funds opened new Aravive, Inc. Common Stock positions in Q2 2019 and 2 closed out, a net change of +1 holder.
  • The largest Aravive, Inc. Common Stock buyer in Q2 2019 was Baker Bros. Advisors, an estimated $337K added.
  • The largest Aravive, Inc. Common Stock seller in Q2 2019 was Spark Investment Management, an estimated $92K sold.

Based on aggregated 13F filings for Q2 2019.